Effects of oxycodon and venlafaxine on human pain processing

Phase 1

• Conditions: Healthy volunteers - pain; MedDRA version: 16.1Level: LLTClassification code 10049475Term: Chronic painSystem Organ Class: 100000004867; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2013-000170-30-DK
• Lead Sponsor: Mech-Sense, Aalborg University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-19
• Study Completion: 2014-12-12
• Last Update Posted: 10 August 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

•Signed informed consent before any study specific procedures
•Able to read and understand Danish.
•The researcher believes that the participant understands what the study entails, are capable of following instructions, are able to attend when needed, are expected to complete the study
•Male
•Between 20 and 35 years of age
•Healthy

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Female
•Known allergy towards pharmaceutical compounds similar to those used in the study
•Participation in other studies within 14 days of first visit
•Expected need of medical/surgical treatment during the course of the study
•History of psychiatric illness
•History of persistent or recurring pain conditions
•History of substance abuse
•Family history of substance abuse
•Use of any analgesic medication within 24 hours before start as well as for the duration of the study period
•Use of prescription medicine and/or herbal medicine
•Need to drive motor vehicle within the treatment periods

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified